For patients with advanced disease treatment with cisplatin based chemotherapy is generally curative with the overall cure rates approaching 80% [ 1].
Although treatment experience is limited owing to the rarity of this condition, our case report illustrates that, depending on a patient's overall condition, complete curative resection might be considered a valid therapeutic option when treating myxoid liposarcoma with breast metastasis.
In a recent study the overall survival following curative treatment approaches for HCC was increased in NASH compared to patients with HCV and/or alcoholic liver disease [ 20].
The mean overall survival after curative hepatectomy was 58.2 ± 3.1 months, and the mean disease-free survival was 26.2 ± 2.1 months (Table 2).
By contrast, the overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be only 2.3% in Australia and 2.1% in the USA (Morgan et al., 2004).
Overall sensitivity for curative surgery for upper GI cancer from the APDC was 84% (95%CI 73-92%), ranging from 67%9595% CI 24-94%) for oesophageal cancer to 91% (95%CI 57-99%) for liver cancer.
Most nomograms for Gastric Cancer (GC) were developed to predict overall survival (OS) after curative resection.
Extensive disease of cholangiocarcinoma (CC) determines the overall outcome and limits curative resection.
